A detailed history of Israel Englander (Millennium Management LLC) transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Millennium Management LLC holds 210,756 shares of ORGO stock, worth $590,116. This represents 0.0% of its overall portfolio holdings.

Number of Shares
210,756
Previous 946,214 77.73%
Holding current value
$590,116
Previous $3.87 Million 84.55%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$2.61 - $4.49 $1.92 Million - $3.3 Million
-735,458 Reduced 77.73%
210,756 $598,000
Q4 2023

Feb 14, 2024

SELL
$1.97 - $4.21 $2.43 Million - $5.19 Million
-1,232,872 Reduced 56.58%
946,214 $3.87 Million
Q2 2023

Aug 14, 2023

BUY
$1.9 - $4.3 $1.13 Million - $2.56 Million
594,812 Added 37.54%
2,179,086 $7.23 Million
Q1 2023

May 15, 2023

SELL
$1.89 - $2.93 $270,247 - $418,954
-142,988 Reduced 8.28%
1,584,274 $3.38 Million
Q4 2022

Feb 14, 2023

BUY
$2.48 - $3.43 $574,697 - $794,844
231,733 Added 15.5%
1,727,262 $4.65 Million
Q3 2022

Nov 14, 2022

BUY
$3.14 - $6.43 $2.92 Million - $5.98 Million
929,727 Added 164.32%
1,495,529 $4.85 Million
Q2 2022

Aug 15, 2022

SELL
$4.74 - $8.15 $4.06 Million - $6.98 Million
-856,176 Reduced 60.21%
565,802 $2.76 Million
Q1 2022

May 16, 2022

BUY
$6.47 - $9.57 $1.47 Million - $2.18 Million
227,852 Added 19.08%
1,421,978 $10.8 Million
Q4 2021

Feb 14, 2022

BUY
$9.02 - $13.5 $6.3 Million - $9.43 Million
698,263 Added 140.82%
1,194,126 $11 Million
Q3 2021

Nov 15, 2021

SELL
$13.71 - $17.18 $6.78 Million - $8.5 Million
-494,584 Reduced 49.94%
495,863 $7.06 Million
Q2 2021

Aug 16, 2021

BUY
$14.92 - $23.23 $11.3 Million - $17.6 Million
758,062 Added 326.21%
990,447 $16.5 Million
Q1 2021

May 17, 2021

BUY
$7.33 - $21.06 $992,364 - $2.85 Million
135,384 Added 139.57%
232,385 $4.23 Million
Q4 2020

Feb 16, 2021

BUY
$3.63 - $7.53 $352,113 - $730,417
97,001 New
97,001 $730,000
Q2 2020

Aug 14, 2020

SELL
$2.86 - $4.61 $225,814 - $363,987
-78,956 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$2.92 - $5.31 $241,863 - $439,827
-82,830 Reduced 51.2%
78,956 $255,000
Q4 2019

Feb 14, 2020

BUY
$4.7 - $8.11 $760,394 - $1.31 Million
161,786 New
161,786 $778,000
Q3 2019

Nov 14, 2019

SELL
$3.57 - $8.09 $60,254 - $136,543
-16,878 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$6.58 - $8.69 $278,577 - $367,908
-42,337 Reduced 71.5%
16,878 $128,000
Q1 2019

May 14, 2019

BUY
$7.05 - $150.0 $417,465 - $8.88 Million
59,215 New
59,215 $444,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $366M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.